INFARMED organizes this Thursday and Friday (April 29th and 30th) an international conference that will bring together the main European and world players in Medicines and Medical Devices. The event will be public and in virtual format and require already available registration. More information here.
The European Commission will be represented by the Commissioner for Health, Stella Kyriakides. The World Health Organization (WHO) Director-General, Tedros Ghebreyesus, will participate in the opening of the Conference. From the European Parliament, Dolors Montserrat, will represent the Committee on the Environment, Public Health. On behalf of the Portuguese Government will be the Minister of Health, Marta Temido, and the Secretary of State of Health, Diogo Serras Lopes. The President of INFARMED, Rui Santos Ivo, will also speak at the Conference.
Also present will be some of the officials who in the last year have assumed a more prominent role in the public domain due to the pandemic, such as the executive director of the European Medicines Agency (EMA), Emmer Cooke, and its deputy director, Noël Wathion.
Participants will also have the opportunity to hear from the EC Directorate-General for Health and Food Safety, Andrzej Rys, the President of the European Patients' Forum, Marco Greco, and the President of the Competent Authorities for Medical Devices, Thomas Wejs Møller.
The Conference theme will be the "Availability, Accessibility and Sustainability of Medicines and Medical Devices" (which gives the name to the 3A's of the Conference - Availability, Accessibility and Affordability).
The conference aims to discuss the specific topics assumed as priorities in this area by the Portuguese Presidency in order to build a convergent position among participants that will then allow the presentation of a set of concrete measures to be adopted as conclusions of the Council of the European Union.
Since the beginning of the year, the Portuguese Presidency, through the Ministry of Health and INFARMED, has advocated and worked to contribute to the construction of a European Health Union, within the framework of the implementation of the Pharmaceutical Strategy for Europe, recently adopted by the European Commission, and has taken steps to support the strengthening of the role of European agencies and their coordination with the national agencies of the Member States.
The event is structured to promote cooperation and collaboration among EU Member States. During the two-day conference, participants will address pricing and reimbursement policies, the cost-effectiveness of medicines, how public support reflects on price, regional collaboration, as well as transparency along the value chain and the sustainability of European health systems.
It will also look at new and better ways to ensure access and affordability in areas where there are unmet needs and how to improve the market launch of centrally authorized products.
April 27, 2021